This study is in progress, not accepting new patients
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
a study on Prostate Cancer
Prostatic NeoplasmsMetastatic Castration-Resistant Prostate CancerMetastatic Castration-Resistant Prostate Cancer (mCRPC)Prostate cancerAbiraterone Acetate (ZYTIGA)PrednisoneJNJ-56021927Abiraterone Acetate
Lead Scientist at UCSF
- Terence Friedlander
I am a clinical and translational oncologist specializing in cancers of the genitourinary tract, specifically bladder and prostate cancers. My research is focused on understanding the basic biology these malignancies and in developing novel therapeutic ways to treat disease.
- in progress, not accepting new patients
- Start Date
- Completion Date
- Aragon Pharmaceuticals, Inc.
- Phase 1
- Study Type
- Last Updated